insights_auto
Why is EW up 2.55%?
Dive Deeperchevron_right
EW:NYSE
Edwards Lifesciences Corp
US$104.71
arrow_upward
+2.55%(+2.60) 1D
US$104.71
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 9, 4:00:04 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
US$102.85
High
US$105.37
Low
US$102.17
Mkt. cap
60.21 ቢ
Avg. vol.
4.37 ሚ
Volume
6.68 ሚ
P/E ratio
59.36
52-wk high
US$105.37
52-wk low
US$74.66
EPS
US$1.76
Beta
0.85
Shares outstanding
575.00 ሚ
No. of employees
16 ሺ
Open
US$102.85
High
US$105.37
Low
US$102.17
Mkt. cap
60.21 ቢ
Avg. vol.
4.37 ሚ
Volume
6.68 ሚ
P/E ratio
59.36
52-wk high
US$105.37
52-wk low
US$74.66
EPS
US$1.76
Beta
0.85
Shares outstanding
575.00 ሚ
No. of employees
16 ሺ
News stories
From web sources and news partners
Investing.com Canada
·
ከ5 ሰዓቶች በፊት
Form 144 Edwards Lifesciences Corp For: 9 November By Investing.com
News Corp
·
ከ5 ሰዓቶች በፊት
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com
·
ከ11 ሰዓቶች በፊት
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Investing.com
·
ከ18 ሰዓቶች በፊት
Edwards Lifesciences CVP Daveen Chopra sells $2.9M in stock
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ሺ
Founded1958
Headquartersኢርቪን, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryMedical device
Websiteedwards.com